ESC Guidelines Classification Scheme: Difference between revisions

Jump to navigation Jump to search
Aravind Kuchkuntla (talk | contribs)
Aravind Kuchkuntla (talk | contribs)
Line 5: Line 5:
The '''Class''' designation is used to indicate whether a therapy is recommended or not and the certainty surrounding that recommendation.
The '''Class''' designation is used to indicate whether a therapy is recommended or not and the certainty surrounding that recommendation.


==Classes of Recommendation <ref name="pmid229224152">{{cite journal| author=Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC). European Association for Cardio-Thoracic Surgery (EACTS). Vahanian A, Alfieri O, Andreotti F, Antunes MJ et al.| title=Guidelines on the management of valvular heart disease (version 2012). | journal=Eur Heart J | year= 2012 | volume= 33 | issue= 19 | pages= 2451-96 | pmid=22922415 | doi=10.1093/eurheartj/ehs109 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22922415  }}</ref>==
==Classes of Recommendation ==


===Class I:===
===Class I:===

Revision as of 22:16, 20 December 2016

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

The Class designation is used to indicate whether a therapy is recommended or not and the certainty surrounding that recommendation.

Classes of Recommendation

Class I:

Conditions for which there is evidence and/or general agreement that a given procedure or treatment is beneficial, useful, and effective.

Class II:

Conditions for which there is conflicting evidence and/or a divergence of opinion about the usefulness/efficacy of a procedure or treatment.

Class IIa:

Weight of evidence/opinion is in favor of usefulness/efficacy.

Class IIb:

Usefulness/efficacy is less well established by evidence/opinion.

Class III

Conditions for which there is evidence and/or general agreement that a procedure/treatment is not useful/effective and in some cases may be harmful.

Level Of Evidence

Level of Evidence A:

Data derived from multiple randomized clinical trials or meta-analyses of such studies.

Level of Evidence B:

  • Data derived from one or more randomized trials or meta-analysis of such studies.
  • Data derived from one or more non-randomized trials or meta-analysis of such studies.

Level of Evidence C:

  • Non randomized observational studies with limitations in design or execution or Metanalysis of such studies.
  • Consensus opinion of experts based on clinical experience.

Applying Classification of Recommendations and Level of Evidence

2016 Classification of Recommendations and Level of Evidence

References

Template:WH Template:WS